FR
Fabrice Rosenstiehl
Chief Operating Officer at SEPARATIVE
Paris, Île-de-France
Overview
Fabrice Rosenstiehl is a Chief Executive Officer with expertise in business development, sales, marketing, and market access within the medical technology industry, particularly in cardiology, DTx, and neuroscience. With a successful track record at companies like Corstim and Digitsole, he has demonstrated strong leadership in driving operational excellence and customer satisfaction, while also investing in various startups in the digital health sector.
Work Experience
Chief Operating Officer
2022 - Current
Interim COO at Separative: Designed and executed a scale-up roadmap; achieved €1M BPI "1ère usine" grant and raised $3.4M from CVC/EIC/French Family Office, enabling the company to pursue their product development.
Founder, Senior Advisor
2019
Led high-impact transition management and strategic advisory missions across MedTech, Digital Health, Chemistry, and Marketing sectors. Delivered accelerated scaling, organizational realignment, crisis recovery, and fundraising execution.
Business Angel
2018
Director TRI Europe
2022 - 2025
Strategic and Business Advisor - Strategic Planning & Execution - Fund Raising
Chairman & CEO
2022 - 2022
Chief Operating Officer
2021 - 2021
General Manager
2020 - 2021
Group Operations Director
2019 - 2019
Head of Service Business EMEA
2017 - 2018
Head of Customer and Business Development EMEA
2008 - 2016
EMEA Growth Probes Manager
2007 - 2008
Region Services Manager MEA
2003 - 2007
Six Sigma Black Belt
2001 - 2002
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers.
Raised $5,524,660,836.00 from Bill & Melinda Gates Foundation.
Supplier Manager
2000 - 2001
Education
MSc
1996 - 1997
Driving Strategic Innovation
2018 - 2018
Diverse Executive Programs
2009 - 2018
Graduate
1993 - 1996